Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  2016-06-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00280-016-3080-0PMID 27339150
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The short-term outcomes of induction SOX (S-1 + oxaliplatin) ± cetuximab chemotherapy followed by short-course chemoradiotherapy in patients with poor-risk locally advanced rectal cancer

  2016cited by this paper
• Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma

  2016cited by this paper
• A pilot study on the impact of known drug-drug interactions in cancer patients

  2015cited by this paper
• Guideline on aspects of cancer‐related venous thrombosis

  2015cited by this paper
• Effect of antidepressant drugs on cytochrome P450 2C11 (CYP2C11) in rat liver

  2013cited by this paper
• Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs

  2013cited by this paper
• Individual differences in prothrombin time-international normalized ratio variation following coadministration of the anticancer agents S-1 and warfarin: 3 case reports.

  2011cited by this paper
• Adverse Interaction between Capecitabine and Warfarin Resulting in Altered Coagulation Parameters: A Review of the Literature Starting from a Case Report

  2010cited by this paper
• Comparison of the 5‐Fluorouracil‐Warfarin and Capecitabine‐Warfarin Drug Interactions

  2010cited by this paper
• Increased anticoagulant activity of warfarin used in combination with doxifluridine

  2010cited by this paper
• Development History and Concept of an Oral Anticancer Agent S-1 (TS-1®): Its Clinical Usefulness and Future Vistas

  2008cited by this paper
• Inhibitory effect of 5-fluorouracil on cytochrome P450 2C9 activity in cancer patients.

  2006cited by this paper
• Drug interaction between capecitabine and warfarin: a case report and review of the literature.

  2006cited by this paper
• A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin.

  2006cited by this paper
• An adverse interaction between warfarin and fluoropyrimidines revisited.

  2005cited by this paper
• Capecitabine–Warfarin Interaction

  2005cited by this paper
• Adverse Interaction Between Capecitabine and Warfarin Resulting in Altered Coagulation Parameters and Bleeding: Case Report and Review of the Literature

  2005cited by this paper
• Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer.

  2005cited by this paper
• How I treat venous thromboembolism in patients with cancer.

  2005cited by this paper
• High incidence of haemostatic interference in cancer patients treated with FOLFOX regimen and concomitant minidose of warfarin

  2005cited by this paper
• Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen.

  2003cited by this paper
• Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?

  2003cited by this paper
• The rational development of capecitabine from the laboratory to the clinic.

  2002cited by this paper
• An adverse interaction between warfarin and capecitabine: a case report and review of the literature.

  2001cited by this paper
• Role of Desethylamiodarone in the Anticoagulant Effect of Concurrent Amiodarone and Warfarin Therapy

  2001cited by this paper
• Warfarin—5‐FU Interaction — A Consecutive Case Series

  1999cited by this paper
• Multisite Mucous Membrane Bleeding Due to a Possible Interaction Between Warfarin and 5‐Fluorouracil

  1997cited by this paper
• Human P450 metabolism of warfarin.

  1997cited by this paper
• Modulation of the expression on constitutive rat hepatic cytochrome P450 isozymes by 5-fluorouracil.

  1996cited by this paper
• Effects of 5-fluorouracil treatment on rat liver microsomal enzymes.

  1995cited by this paper
• Fluorouracil: biochemistry and pharmacology.

  1988cited by this paper
• Case Report and Review of the Literature: Ureteral Endometriosis

  1987cited by this paper

• Impact of Chemotherapy and Anticancer Agent Type on 30-Day All-Cause In-Hospital Mortality of Venous Thromboembolism Patients With Cancer in Japan

  2025cites this paper
• Changes in Pharmacodynamic Parameters during Co-administration of 5-FU with Warfarin: A Retrospective Case Series.

  2022cites this paper
• Anticoagulation in Cancer Patients: a Summary of Pitfalls to Avoid

  2019cites this paper
• Prolonged Pharmacokinetic Interaction Between Capecitabine and a CYP2C9 Substrate, Celecoxib

  2019cites this paper
• Evaluation of the anticoagulant effect and timing of the concomitant use of S-1 and warfarin

  2016influential citation